Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary (2005)
Chapter: Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults
Appendix A
Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults
Lecture Room
National Academy of Sciences Building
2101 Constitution Avenue NW
Washington, D.C. 20418
January 26–27, 2004
Day 1
8:30–9:00 | Continental Breakfast, Lecture Room |
9:00–9:30 | Welcome and Introduction to the Workshop Louise Russell, Ph.D., Rutgers University, Workshop Chair Martin Brown, Ph.D., National Cancer Institute, Workshop Co-Chair Judith Wagner, Ph.D., IOM Staff Officer |
PART I:COMPARING ECONOMIC MODELS OF CRC SCREENING
9:30–11:00 | Overview of Five Leading Economic Models of CRC Screening The “Harvard Model”: Karen Kuntz, Sc.D., Harvard University The “Ladabaum Model”: Uri Ladabaum, M.D., University of California at San Francisco The “Miscan Model”: Marjolein van Ballegooijen, M.D., Erasmus University The “Vanderbilt Model”: Reid Ness, M.D., Vanderbilt University The “Vijan Model”: Sandeep Vijan, M.D., University of Michigan |
11:00–11:15 | Break |
11:15–11:45 | Results of a Pre-Workshop Comparative Modeling Exercise Michael Pignone, M.D., University of North Carolina |
11:45–12:45 | Discussion |
12:45–1:15 | Lunch |
PART II:CURRENT EVIDENCE ON COLORECTAL CANCER SCREENING
1:15–2:30 | Evidence on Compliance (Q&A follows presentations) |
| Current Evidence on Compliance Sally Vernon, Ph.D., University of Texas at Houston |
| Recent Follow-up and Compliance Patterns of Medicare Patients Todd Anderson, M.S., Congressional Budget Office |
| The Relationship Between Compliance and Capacity Laura Seeff, M.D., Centers for Disease Control |
2:30–3:15 | Recent Findings on Test Performance Brian Mullhall, M.D., Walter Reed Army Hospital Q&A follows presentation |
3:15–3:30 | Break |
3:30–4:15 | Measuring the Cost of Screening, Follow-up, and Surveillance in Cost-Effectiveness Models Martin Brown, Ph.D. National Cancer Institute Q&A follows presentation |
4:15–5:00 | Evidence on Effectiveness of Follow-up and Surveillance Strategies Deborah Schrag, M.D., Memorial Sloan Kettering Cancer Center Q&A follows presentation |
Day 2
8:30–9:00 | Defining Issues: A Reprise of First Day’s Findings Martin Brown, Michael Pignone, and Judith Wagner |
PART III:MODELING THE NATURAL HISTORY OF COLORECTAL CANCER
9:00–9:45 | Recent Evidence on Natural History T.R.Levin, M.D., Kaiser Permanente Division of Research Q&A follows presentation |
9:45–10:00 | The NCI CISNET Project: An Overview of Goals, Methods, and Current Status Eric Feuer, Ph.D., National Cancer Institute |
10:00–10:15 | Break |
10:15–11:15 | Discussion of Issues in Modeling Natural History |
11:15–12:00 | Modelers’ Forum: Next Steps, Unresolved Questions, Critical Information Needs Marjolein van Ballegooijen, Karen Kuntz, Sandeep Vijan, Reid Ness, Uri Ladabaum and Coauthors |
12:00–1:00 | Discussion and Wrap-up |
1:00 | Adjourn |
